Plasma Injections Plus Exercise for Patellar Tendinopathy (PHS)
Intratendinous Injections of Platelet Rich Plasma With or Without Leukocyte Enrichment for Patellar Tendinopathy: a Randomized Controlled Trial
Sponsor: American Orthopaedic Society for Sports Medicine
Terminated
79% participant retention after 1 year
Other Patellar Tendinopathy trials with similar outcome
Listed as NCT02116946, this PHASE2 trial focuses on Patellar Tendinopathy and remains terminated or withdrawn. Sponsored by American Orthopaedic Society for Sports Medicine, it has been updated 10 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jan 2019 — Jan 2021 [monthly]
Terminated PHASE2
Status: Active Not Recruiting → Terminated
-
Nov 2018 — Jan 2019 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting · Phase: NA → PHASE2
▶ Show 5 earlier versions
-
Jun 2018 — Nov 2018 [monthly]
Recruiting NA
-
Jun 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
-
May 2017 — Jun 2017 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Feb 2017 — May 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Mar 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- American Orthopaedic Society for Sports Medicine
- Norwegian Olympic Sports Center
- Rizzoli Orthopaedic Institute
- Steadman Clinic
- University of British Columbia
- University of Oslo
- University of Washington
For direct contact, visit the study record on ClinicalTrials.gov .